Abeona Therapeutics (ABEO) Depreciation & Amortization (CF) (2011 - 2026)
Abeona Therapeutics (ABEO) posted quarterly Depreciation & Amortization (CF) of $690000.0 for Q1 2026, up 29.21% year-over-year from $534000.0 in Q1 2025, and down 20.05% quarter-over-quarter from $863000.0 in Q4 2025.
Powered by 
Analysis
Abeona Therapeutics (ABEO) Depreciation & Amortization (CF) (2011 - 2026) Analysis & Trends
Abeona Therapeutics' Depreciation & Amortization (CF) history runs 16 years deep, the most recent figure standing at $690000.0 for Q1 2026.
- In Q1 2026, Depreciation & Amortization (CF) rose 29.21% year-over-year to $690000.0; the TTM figure through Mar 2026 stood at $2.7 million (up 32.14% YoY), while the FY2025 annual figure was $2.5 million, up 27.2% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $690000.0, down from $863000.0 in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $863000.0 in Q4 2025, with the low at $487000.0 in Q2 2024.
- The 5-year median for Depreciation & Amortization (CF) is $608000.0 (2025), against an average of $624941.2.
- The sharpest annual moves came in 2023 and 2025: Depreciation & Amortization (CF) sank 33.21% in 2023, then jumped 60.11% in 2025.
- Abeona Therapeutics' Depreciation & Amortization (CF) stood at $729000.0 in 2022, then tumbled by 32.65% to $491000.0 in 2023, then grew by 9.78% to $539000.0 in 2024, then surged by 60.11% to $863000.0 in 2025, then decreased by 20.05% to $690000.0 in 2026.
- Business Quant data shows ABEO's Depreciation & Amortization (CF) at $690000.0 in Q1 2026, $863000.0 in Q4 2025, and $608000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 56.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 123.70 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 40.52 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Abeona Therapeutics | 342.29 Mn | 195.46 Mn | 7.20 Mn | 665,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 665,000.00 |
| Mar 31, 2026 | 690,000.00 |
| Dec 31, 2025 | 863,000.00 |
| Sep 30, 2025 | 608,000.00 |
| Jun 30, 2025 | 544,000.00 |
| Mar 31, 2025 | 534,000.00 |
| Dec 31, 2024 | 539,000.00 |
| Sep 30, 2024 | 487,000.00 |
| Jun 30, 2024 | 487,000.00 |
| Mar 31, 2024 | 491,000.00 |
| Dec 31, 2023 | 491,000.00 |
| Sep 30, 2023 | 521,000.00 |
| Jun 30, 2023 | 615,000.00 |
| Mar 31, 2023 | 661,000.00 |
| Dec 31, 2022 | 729,000.00 |
| Sep 30, 2022 | 780,000.00 |
| Jun 30, 2022 | 773,000.00 |
| Mar 31, 2022 | 811,000.00 |
| Dec 31, 2021 | 807,000.00 |
| Sep 30, 2021 | 802,000.00 |